טוען...
What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?
The use of biological agents and immunomodulators for inflammatory bowel disease (IBD) is associated with an increased risk of opportunistic infections, in particular of viral or bacterial etiology. Despite the existence of international guidelines, many gastroenterologists have not adopted routine...
שמור ב:
| הוצא לאור ב: | World J Gastrointest Pharmacol Ther |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Baishideng Publishing Group Inc
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4986392/ https://ncbi.nlm.nih.gov/pubmed/27602239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4292/wjgpt.v7.i3.387 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|